Kelvin K. Womack - 09 Aug 2021 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Kelvin K. Womack pursuant to Power of Attorney filed herewith.
Issuer symbol: CSII
Transactions as of: 09 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 11 Aug 2021, 19:22:45 UTC
Next filing: 09 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Award	$0	+3,814		$0.000000	3,814	09 Aug 2021	Common Stock	3,814		Direct	F2
holding	CSII	Restricted Stock Units						3,856	09 Aug 2021	Common Stock	3,856		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Compoany common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.

Content

Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.